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The Brucella abortus virB locus is required for establishing chronic infection in the mouse. Using in vitro and
in vivo models, we investigated whether virB is involved in evasion of the bactericidal activity of NADPH
oxidase and the inducible nitric oxide synthase (iNOS) in macrophages. Elimination of NADPH oxidase or
iNOS activity in macrophages in vitro increased recovery of wild-type B. abortus but not recovery of a virB
mutant. In mice lacking either NADPH oxidase or iNOS, however, B. abortus infected and persisted to the same
extent as it did in congenic C57BL/6 mice up until 60 days postinfection, suggesting that these host de-
fense mechanisms are not critical for limiting bacterial growth in the mouse. A virB mutant did not exhibit
increased survival in either of the knockout mouse strains, indicating that this locus does not contribute to
evasion of nitrosative or oxidative killing mechanisms in vivo.
Brucella species are facultatively intracellular pathogens
whose host range includes livestock, wild animals, and humans.
Following infection of susceptible hosts, bacteria localize to
tissues of the reticuloendothelial system and survive intracel-
lularly within professional macrophages. The mechanisms by
which brucellae are able to avoid killing by macrophages are
unknown. The ability of Brucella abortus to persist in the mac-
rophage suggests that it is able to avoid or withstand phagocyte
killing mechanisms, such as lysosomal enzymes and products of
the oxidative burst (3).
The B. abortus virB locus, a region on chromosome II with
homology to type IV secretion systems, is required for estab-
lishing and maintaining persistent infection in the mouse
model (11, 22). This locus has also been found to be required
for intracellular survival in macrophages and HeLa cells (17,
30, 39). Recent evidence suggests that the virB locus mediates
secretion of an unknown effector(s) required for establishment
of an intracellular compartment favorable for bacterial repli-
cation in HeLa cells (5, 10). This hypothesis is supported by the
finding that expression of the Brucella suis virB operon is in-
duced intracellularly (4). To determine whether B. abortus is
able to avoid intracellular degradative pathways, the trafficking
of B. abortus was studied in nonphagocytic cells (12–14, 32–35).
Results of these studies suggest that B. abortus avoids fusion
with lysosomes and localizes to a compartment containing pro-
teins characteristic of rough endoplasmic reticulum and auto-
phagosomes.
Studies of trafficking in macrophages suggest that the intra-
cellular fate of B. abortus in these cells appears to be distinct
from the well-described localization in nonphagocytic cells (2).
Recent work suggests that B. abortus and B. suis survive in a
compartment that acidifies but has delayed fusion with lyso-
somes (2, 37). Thus, as in nonphagocytic cells, Brucella appears
to delay or modify the maturation of its vacuolar compartment.
In addition, B. abortus has been found to inhibit bactericidal
functions of phagocytes, including phagolysosomal fusion, neu-
trophil degranulation, and the oxidative burst (2, 3, 28).
Brucella spp. share the ability to modulate the composition
of intracellular compartments with several other intracellular
bacterial pathogens, including Legionella, Mycobacterium, and
Salmonella. Salmonella enterica serovar Typhimurium prevents
assembly of the NADPH oxidase complex on phagosomes,
which allows it to avoid the toxic products of the oxidative
burst, and this activity is dependent on the Salmonella patho-
genicity island 2 type III secretion system (40). Interestingly, an
ultrastructural study examining the localization of NADPH
oxidase in B. abortus-infected macrophages found that vacu-
oles containing B. abortus tended not to be associated with
NADPH oxidase (18), suggesting that B. abortus might employ
similar mechanisms for survival within phagocytes. In the pres-
ent study, we sought to determine whether the virB locus con-
tributes to evasion of NADPH oxidase- and inducible nitric ox-
ide synthase (iNOS)-mediated control of bacterial growth during
B. abortus infection of cultured macrophages and of mice.
MATERIALS AND METHODS
Bacterial strains, media, and culture conditions. The bacterial strains which
we used are B. abortus 2308 and its isogenic mutant BA41, which has an insertion
of mTn5Km-2 at nucleotide 1232 of the B. abortus virB locus (GenBank accession
number AF226278). This insertion is located 59 bp downstream of the virB1 gene
and is polar on the expression of downstream genes in the virB operon (data not
shown). Strains were cultured on tryptic soy agar (TSA) (Difco/Becton-Dickin-
son, Sparks, Md.) or in tryptic soy broth at 37°C on a rotary shaker. Bacterial
inocula used for infection of mice were cultured on potato infusion agar, as
growth on this medium prevents appearance of spontaneous rough mutants (1).
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Antibiotics, when required, were added at the following concentrations: carben-
icillin, 100 mg/liter; kanamycin, 100 mg/liter; and chloramphenicol, 5 to 30
mg/liter. All work with live B. abortus was performed at biosafety level 3.
Cell lines. Two clones of the mouse macrophage-like cell line J774, J774.16
and J774.D9, were cultured in Dulbecco’s modified Eagle’s medium (Gibco,
Rockville, Md.) supplemented with 10% heat-inactivated equine serum, 1%
nonessential amino acids, and 1 mM glutamine (DMEMsup). The ability or
inability of these cell lines to generate oxygen radicals via the hexose monophos-
phate shunt (oxidative burst) after induction with phorbol myristyate acetate
(Sigma) was confirmed as described elsewhere (9, 19).
For macrophage killing assays, 24-well microtiter plates were seeded with
macrophages at a concentration of 5 105 cells/well in 0.5 ml of DMEMsup and
incubated overnight at 37°C in the presence of 5% CO2. For experiments with
activated macrophages, 10 U of recombinant murine gamma interferon (IFN-)
(Endogen, Woburn, Mass.) per ml was added to the medium 24 h before infec-
tion, and this concentration of IFN- was maintained throughout the assay by
replacing the medium every 24 h. Bacteria were grown for 48 h and then diluted
in DMEMsup, and about 5  107 bacteria in 0.02 ml of DMEMsup were added
to each well containing macrophages. The microtiter plates were centrifuged at
250  g for 5 min at room temperature in order to synchronize the infections.
Cells were incubated for 20 min at 37°C in the presence of 5% CO2, free bacteria
were removed by three washes with phosphate-buffered saline (PBS), and the
zero-time samples were taken as described below. The washing solutions were
collected, and extracellular bacteria were quantified by dilution in sterile PBS
and plating on TSA. DMEMsup containing 50 g of gentamicin per ml was
added to the wells, and the cells were incubated at 37°C in the presence of 5%
CO2. After 1 h, the DMEMsup containing 50 g of gentamicin per ml was
replaced with medium containing 25 g of gentamicin per ml. Wells were sam-
pled at zero time and 24 and 48 h after infection by aspirating the medium, lysing
the macrophages with 0.5 ml of 0.5% Tween 20, and rinsing each well with 0.5 ml
of PBS. Viable bacteria were quantified by dilution in sterile PBS and plating on
TSA. All experiments were performed independently in triplicate at least three
times, and the standard error for each time point was calculated.
Isolation and infection of mouse peritoneal macrophages. As a previous study
revealed that only low levels of NO were produced by proteose peptone-elicited
murine peritoneal macrophages infected with B. abortus, we used a method that
allowed us to obtain macrophages that produced both iNOS and NADPH oxi-
dase (24). Elicited peritoneal macrophages were isolated from C57BL/6 mice by
peritoneal lavage 4 days after injection of 5 mM sodium periodate, which stim-
ulates both the phagocyte respiratory burst and inducible NO synthase (15). Cells
were seeded into 96-well plates at a concentration of 3  105 cells/well and
allowed to adhere to the plastic overnight. For activation, cells were incubated
overnight in the presence of 20 U of murine recombinant interferon (IFN-;
Endogen) per ml and 1 pg of S. enterica serovar Typhimurium lipopolysaccharide
(LPS) (Sigma, St. Louis, Mo.) per ml. Cells were used for macrophage killing
assays as described above for macrophage cell lines. For inhibition of iNOS, 250
M NG-L-monomethyl arginine (MMLA) (Sigma) was maintained in the tissue
culture medium throughout the assay. NO production by peritoneal macro-
phages was assayed by incubating macrophage supernatants with an equal vol-
ume of Griess reagent (Sigma) and measuring absorbance at 570 nm to deter-
mine the nitrite concentration.
Infection of mice. All mice used in this study were derived from the C57BL/6
strain. C57BL/6 mice and C57BL/6-Cybbtm1 mice carrying a targeted knockout
of the gene encoding gp91 (gp91phox) of NADPH oxidase (36) were obtained
from Jackson Laboratory (Bar Harbor, Maine). C57BL/6 Ai-[KO]iNOS N5 mice
carrying a targeted knockout of the Nos2 gene encoding iNOS were obtained
from Taconic (Germantown, N.Y.) (26). Mice were kept in microisolator cages
with sterile bedding and water and irradiated feed in a biosafety level 3 facility.
For infection experiments, groups of five knockout mice and age-matched con-
trols were inoculated intraperitoneally (i.p.) with 0.2 ml of PBS containing 5 
105 to 10  105 CFU of B. abortus. At the appropriate times, mice were
euthanized by CO2 asphyxiation, and the spleens and livers were collected asep-
tically at necropsy. A portion (one-quarter) of the spleen and the liver of each
mouse were fixed in phosphate-buffered formalin and processed for sectioning
and staining with hematoxylin and eosin. The remaining three-quarters of the
spleen was homogenized in 3 ml of PBS, and serial dilutions of the homogenate
were plated on TSA and TSA containing kanmycin for enumeration of CFU. The
competitive index was calculated by dividing the mean ratio of mutant CFU to
wild-type CFU recovered from spleens by the ratio of the mutant CFU to the
wild-type CFU in the inoculum. The experimental groups each contained four or
five knockout mice and four or five age-matched controls that were 6 to 10 weeks
old. Hematoxylin- and eosin-stained sections of the spleen and liver from each
mouse were coded and scored for pathological changes by a veterinary pathol-
ogist. All animal experiments were approved by the Texas A&M University
Laboratory Animal Care and Use Committee and were conducted in accordance
with institutional guidelines.
RESULTS
Intracellular survival of B. abortus in macrophages unable
to produce superoxide. In order to determine whether the
oxidative burst is required for control of B. abortus infection by
macrophages, we compared the data for survival of B. abortus
2308 and its isogenic virB mutant in two clones of the J774 cell
line that differ in the ability to produce an oxidative burst upon
activation. J774.16 cells produce superoxide (O2
) upon acti-
vation with IFN-, while J774.D9 cells do not produce detect-
able levels of O2
 due to a lack of expression of the cybb gene
encoding the cytochrome b558 (gp91) subunit of NADPH oxi-
dase (19). In the absence of IFN- activation, there was no
significant difference (P  0.05) in the numbers of B. abortus
CFU (either mutant or wild type) recovered from J774.16 and
J774.D9 cells at 48 h after infection (Fig. 1A). The numbers of
virB mutant BA41 CFU recovered from both J774 clones at
48 h were approximately 1% the numbers of the wild-type
CFU recovered, in agreement with previous reports (30, 39).
The numbers of cell-associated CFU of B. abortus 2308 and the
virB mutant determined at zero time were similar, suggesting
that there were no differences in internalization of the two
strains (data not shown).
In cells activated with IFN- (Fig. 1B), significantly greater
numbers of B. abortus 2308 CFU were recovered from J774.D9
cells than from J774.16 cells (P  0.005), suggesting that pro-
duction of superoxide by activated macrophages is a mecha-
nism that limits intracellular growth of B. abortus. If the virB
locus contributes to avoidance of oxidative killing in activated
cells, we would expect the virB mutant to exhibit increased
survival in cells unable to produce superoxide. Although a
difference in the numbers of virB mutant BA41 CFU recovered
FIG. 1. Survival of B. abortus 2308 and isogenic virB mutant BA41
in J774.16 cells (open bars), which generate an oxidative burst upon
activation, and J774.D9 cells (solid bars), which lack a complete
NADPH oxidase. Cells were incubated for 24 h without IFN- (A) or
with IFN- (B) and subsequently were infected with B. abortus 2308 or
BA41. The numbers of intracellular CFU of B. abortus were deter-
mined 48 h postinoculation. Each bar indicates the mean  standard
deviation for a total of six data samples (from two independent exper-
iments, each containing triplicate samples). Data were analyzed by
using a Student’s t test. Statistically significant differences between
survival in J774.16 cells and survival in J774.D9 cells are indicated by
asterisks (P  0.05). The two J774 clones had equal numbers of
cell-associated B. abortus CFU at zero time (data not shown). wt, wild
type.
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from the two cell lines was observed at 48 h after infection (Fig.
1), this difference was not significant. Thus, these data did not
suggest that the the virB locus protects B. abortus against oxi-
dative killing by macrophages in vitro.
gp91phox gene knockout mice are able to control replication
of both B. abortus wild type and the virB mutant to the same
extent as C57BL/6 mice. In order to determine whether
NADPH oxidase may play a role in controlling B. abortus
infection in vivo and whether the virB locus may play a role in
evasion of this killing mechanism in the host, we performed
mixed-infection experiments with C57BL/6 mice and with mice
carrying a targeted knockout of the cybb gene encoding the
gp91 cytochrome b subunit (gp91phox) of NADPH oxidase (36).
Mixed infections were used in order to provide an internal
control for the level of infection with wild-type B. abortus in
each animal. Each mouse was injected i.p. with a mixed inoc-
ulum containing approximately 5 105 CFU of B. abortus 2308
and 5  105 CFU of BA41 (virB), and the CFU of each
challenge strain were enumerated in spleen homogenates 14
and 60 days postinfection. If NADPH oxidase is required for
control of B. abortus in vivo, the gp91phox knockout mice
should harbor higher total numbers of B. abortus. If virB is
required for evasion of oxidative killing in this model, the ratio
of the CFU of the virB mutant to the CFU of the wild type
would be expected to increase in the knockout mice relative to
the ratio in C57BL/6 mice.
Figure 2 shows that at 2 weeks postinfection, although the
total number of B. abortus CFU recovered from the spleens of
gp91phox knockout mice was slightly higher than the total num-
ber of B. abortus CFU recovered from the spleens of C57BL/6
mice, the two groups did not differ significantly (P 	 0.30),
suggesting that NADPH oxidase is dispensable for control of
B. abortus infection in vivo. Similarly, at 60 days postinocula-
tion, we observed no significant difference between the two
strains in terms of the number of wild-type or virB mutant
bacteria recovered from the spleens. Furthermore, the ratios of
virB mutant BA41 CFU to wild-type strain 2308 CFU also did
not differ significantly at either time point, arguing against a
role for the virB locus in evasion of this killing mechanism in
mice. A control experiment in which C57BL/6 and gp91phox
knockout mice were infected individually with B. abortus 2308
or BA41 (virB) resulted in numbers of wild-type and mutant
bacteria in the spleens similar to the numbers obtained in the
mixed-infection experiment. This result confirmed that wild-
type B. abortus was not able to rescue the virB mutant in vivo
by providing virB-mediated functions in trans (data not shown).
Inhibition of iNOS in activated peritoneal macrophages in-
creases intracellular survival of the B. abortus wild type but
not the virB mutant. Like NADPH oxidase, iNOS (or NOS2)
is a bactericidal enzyme whose activity increases in response to
macrophage activation. We next sought to determine whether
the virB locus mediates evasion of NO-mediated killing. The
J774 cell lines used for previous experiments did not produce
NO upon activation with IFN- and B. abortus infection (data
not shown). Therefore, in order to determine whether NO
produced by the macrophages is bactericidal, we measured the
effect of inhibition of iNOS on survival of the B. abortus wild
type and virB mutant BA41 in elicited peritoneal macrophages
from C57BL/6 mice. Production of NO by macrophages was
quantified by using the Griess reagent that measures nitrite, a
reaction product of NO. Table 1 shows that periodate-elicited
peritoneal macrophages produced only low levels of nitrite
when they were infected with either the B. abortus wild type or
the virB mutant and that these low levels were not reduced by
treatment of cells with the iNOS inhibitor MMLA. These data
document that B. abortus infection does not activate iNOS in
these cells. However, activation of macrophages with 20 U of
murine IFN- per ml and 1 pg of LPS per ml prior to infection
increased the production of NO both by uninfected cells and by
B. abortus-infected cells. NO production by activated macro-
FIG. 2. Effect of NADPH oxidase on growth of B. abortus 2308 and
the virB mutant in mouse spleens. Groups of 10 C57BL/6 mice and 10
gp91phox knockout mice were inoculated i.p. with a mixture containing
equal amounts of B. abortus 2308 and the virB mutant. The CFU of
each strain were enumerated in the spleens of five mice from each
group at 14 days and 60 days postinoculation. For each mouse, the
results are indicated by one circle (log CFU of the wild type) and one
square (log CFU of the virB mutant). The open circles indicate the log
CFU of B. abortus 2308 recovered from the spleens of C57BL/6 mice,
and the open squares indicate the log CFU of the virB mutant recov-
ered from the spleens of C57BL/6 mice. The solid circles indicate the
log CFU of B. abortus 2308 recovered from gp91phox knockout mice,
and the solid squares indicate the log CFU of the virB mutant recov-
ered from the spleens of gp91phox knockout mice. The means of the
data are indicated by horizontal lines. The competitive index was
calculated by dividing the mean ratio of mutant CFU to wild-type CFU
recovered from spleens by the ratio of the mutant CFU to the wild-
type CFU in the inoculum. k/o, knockout.
TABLE 1. NO production by periodate-elicited murine peritoneal
macrophages at 24 h postinfectiona
Inoculum
Nitrite concn (M/105 cells) in cell supernatants
pretreated with:
None MMLAb IFN-  LPSc IFN-  LPS
 MMLA
Uninfected 3  2 3  2 102  14 5  0.3
B. abortus 2308 11 6 17  10 570 390 43 13
B. abortus virB
mutant
20  5 12  6 244  104 37 16
a The nitrite concentration in 0.05 ml of cell supernatant was measured spec-
trophotometrically at 570 nm after incubation with Griess reagent. The values
are averages  standard deviations for triplicate wells.
b MMLA (250 M) was added to cells after infection with B. abortus.
c Cells were activated 16 h before infection with 20 U of IFN- per ml and 1
pg of LPS per ml.
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phages could be inhibited by MMLA treatment, indicating that
the NO is the product of iNOS activity (Table 1).
In nonactivated macrophages, inhibition of iNOS did not
increase the number of either B. abortus 2308 or virB mutant
BA41 CFU recovered from cells 24 h after inoculation (Fig. 3).
However, in activated macrophages, inhibition of iNOS with
MMLA led to a 10-fold reduction in the amount of NO pro-
duced and resulted in a 10-fold increase in the number of
wild-type B. abortus CFU surviving intracellularly (compared
to nontreated cells; P  0.005) (Fig. 3). In contrast, the virB
mutant was unable to grow within elicited peritoneal macro-
phages, irrespective of IFN- activation (Fig. 3). No difference
in the number of cell-associated CFU was observed for differ-
ent samples, suggesting that similar numbers of bacteria were
internalized in all of the treatment groups (data not shown).
These data indicate that NO generated by activated macro-
phages limits intracellular growth of B. abortus, but the finding
that the virB mutant was not rescued by MMLA treatment of
the macrophages suggests that the virB genes do not act in
evasion of NO.
iNOS knockout mice control growth of a virB mutant better
than C57BL/6 mice control growth of the mutant. To deter-
mine whether the in vitro role of iNOS in limiting intracellular
growth of B. abortus is relevant in the host, we compared the
abilities of C57BL/6 mice and congenic Nos2 knockout mice to
limit B. abortus infection. Mice were inoculated i.p. with a
mixture containing approximately 5  105 CFU of B. abortus
2308 and 5  105 CFU of BA41 (virB), and the CFU of each
challenge strain in the spleens were enumerated 14 and 60 days
postinfection. If iNOS is required for control of B. abortus in
vivo, the Nos2 knockout mice should harbor higher total num-
bers of B. abortus CFU in their spleens than the C57BL/6 mice
harbor. If virB is required for evasion of NO in this model, the
ratio of the number of CFU of the virB mutant to the number
of CFU of the wild type is expected to increase in the Nos2
knockout mice relative to the ratio in the C57BL/6 mice.
At 14 days postinoculation, spleens from Nos2 knockout
mice and C57BL/6 controls contained equivalent total num-
bers of B. abortus (P 	 0.58). Similarly, at 60 days, no differ-
ence in total bacterial load was observed between the two
groups of mice (P 	 0.79), suggesting that the knockout mice
are able to control the infection with B. abortus. Examination
of histological sections of spleens and livers of Nos2 knockout
mice and controls revealed similar pathological findings in the
two mouse strains (data not shown).
Analysis of the mixed-infection data revealed that at 14 days
postinoculation, the Nos2 knockout mice contained signifi-
cantly less of the virB mutant than the wild-type controls con-
tained, which was represented by a lower competitive index (P
	 0.01) (Fig. 4). After 60 days, the two strains of mice were
infected with equivalent numbers of the wild-type bacteria. A
slight difference between the Nos2 knockout and C57BL/6
mice in the numbers of the virB mutant in the spleens was
observed 60 days postinoculation. Three of the four Nos2
knockout mice had cleared the virB mutant, while four of the
five C57BL/6 mice still harbored detectable numbers of the
attenuated strain. However, the differences observed were not
statistically significant (P 	 0.06). These data suggest that
while the Nos2 knockout mice and the control mice harbored
similar numbers of wild-type B. abortus CFU, the Nos2 knock-
FIG. 3. Survival of B. abortus 2308 and the isogenic virB mutant
BA41 in elicited murine peritoneal macrophages. Macrophages were
either not treated (–), treated with the iNOS inhibitor MMLA, acti-
vated with 20 U of murine IFN- per ml and 1 pg of LPS per ml, or
activated and treated with MMLA. The solid bars indicate the number
of intracellular CFU of B. abortus 2308 per well, and the open bars
indicate the number of CFU of BA41 (virB) at 24 h postinoculation.
Each bar indicates the mean  standard deviation for triplicate sam-
ples from a single experiment. Statistical analysis was performed by
using a Student’s t test. The same letter above bars indicates that
differences were not statistically significant (P 0.05). Different letters
above bars indicate that differences were statistically significant at P 
0.05. wt, wild type.
FIG. 4. Effect of iNOS on growth of B. abortus 2308 and the virB
mutant in mouse spleens. Groups of 10 C57BL/6 mice and 10 Nos2
knockout mice were inoculated i.p. with a mixture containing equal
amounts of B. abortus 2308 and the virB mutant. The CFU of each
strain were enumerated in the spleens of five mice from each group at
14 days and 60 days postinoculation. For each mouse, the results are
indicated by one circle (log CFU of the wild type) and one square (log
CFU of the virB mutant). The open circles indicate log CFU of B.
abortus 2308 recovered from the spleens of C57BL/6 mice, and the
open squares indicate log CFU of the virB mutant recovered from the
spleens of C57BL/6 mice. The solid circles indicate log CFU of B.
abortus 2308 recovered from Nos2 knockout mice, and the solid
squares indicate log CFU of the virB mutant recovered from the
spleens of Nos2 knockout mice. The means of the data are indicated by
horizontal lines. The competitive index was calculated by dividing the
mean of mutant CFU recovered from spleens/wild-type CFU recov-
ered from spleens by the ratio of the mutant to the wild type in the
inoculum. k/o, knockout.
VOL. 70, 2002 virB-MEDIATED SURVIVAL OF B. ABORTUS 4829
 o
n
 Septem
ber 21, 2018 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
out mice were able to clear the attenuated virB strain more
rapidly than the C57BL/6 controls. Taken together, these re-
sults indicate that iNOS activity is not required for control of
B. abortus infection in the mouse and that the virB locus does
not play a role in evasion of or resistance to NO.
DISCUSSION
The function of the B. abortus virB locus is essential for
intracellular survival, both in cultured cells and in the mouse
model (17, 22, 30, 39). Disruption of the virB locus results in
failure to traffic to a cellular compartment of HeLa cells that
permits replication (5, 10). However, it is not clear how virB
acts to enable replication of B. abortus in the macrophage, the
cell type in which B. abortus is thought to persist in the host.
Evidence obtained by other investigators suggests that B. abor-
tus is able to inhibit phagosome-lysosome fusion and that
phagosomes containing B. abortus do not contain NADPH
oxidase (2, 18, 28). In order to elucidate the mechanism by
which the virB genes enable B. abortus to survive in the mac-
rophage, we investigated whether the virB locus enables B.
abortus to evade killing by the macrophage NADPH oxidase
and by iNOS.
To determine whether virB mediates evasion of NADPH
oxidase, we examined the intracellular survival of B. abortus
2308 and an isogenic virB mutant in in vitro and in vivo
NADPH oxidase deficiency models. The kinetics of bacterial
replication and killing were examined in two J774 macrophage
clones that differed in the ability to produce the oxidative
burst. When the cells were not activated with IFN- prior to
inoculation with B. abortus, cells of J774.16, the cell line capa-
ble of generating an oxidative burst, and J774.D9 cells, which
are unable to generate superoxide, contained equivalent num-
bers of B. abortus 2308 cells and of virB mutant cells (Fig. 1).
However after activation of these cells with IFN-, the J774.D9
cells contained 2 logs more of B. abortus 2308 and slightly more
of the virB mutant than the clone J774.16 cells contained. This
result suggests that in activated macrophages oxygen-depen-
dent mechanisms are important for killing of B. abortus, but it
did not provide evidence for virB-mediated evasion of NADPH
oxidase. Similarly, when we performed competitive infections
of gp91phox knockout mice and the inbred parent strain, we
found no significant difference in the ratios of the virB mutant
to the wild type recovered from the two mouse strains (Fig. 2).
This result suggests that virB does not play a role in evasion of
oxidative killing in vivo. Interestingly, the total numbers of B.
abortus CFU recovered from the two mouse strains did not
differ significantly, suggesting that in vivo NADPH oxidase is
not required to control B. abortus replication. This result is in
agreement with the findings of Ko et al. (25), which showed
that reactive oxygen intermediates are not required for control
of B. abortus infection in naı¨ve mice.
Inhibition of iNOS in activated peritoneal macrophages in-
creased survival of B. abortus 2308 in vitro, showing that NO
limits bacterial replication in these cells. However, the virB
mutant was unable to grow in these cells, independent of the
activation state or NO production. In Nos2 knockout mice, B.
abortus 2308 replicated to the same extent in the spleen as it
replicated in the parent C57BL/6 strain. However, lower num-
bers of CFU of the virB mutant were recovered from the iNOS
knockout mice than from the C57BL/6 mice, suggesting that
the knockout mice are able to clear the attenuated mutant
more rapidly. At 60 days postinfection, more of the iNOS
knockout mice than of the C57BL/6 mice had cleared the
attenuated virB mutant, although the difference between the
numbers of CFU was not significant (P 	 0.06) (Fig. 3). If the
virB genes are involved in evasion of NO, we would expect to
recover higher rather than lower numbers of CFU of the virB
mutant from the knockout mice. Thus, these data show that
iNOS is dispensable for control of B. abortus infection in vivo
and argue against a role for the virB locus in evasion of nitro-
sative killing in vivo. Splitter and colleagues have found that
high levels of NO production in a macrophage cell line corre-
late with increased survival after prolonged incubation, so
taken together, our findings may indicate that NO production
may in some way be advantageous to the persistence of B.
abortus in vivo (41).
Several investigators have shown that in vitro, either opso-
nization of bacteria with specific antiserum or activation of
cells with IFN- is required in order to detect generation of
O2
 and NO by macrophages when they are challenged with B.
abortus or B. suis (16, 20, 21, 24). Based on these observations,
it has been suggested that these defense mechanisms may play
a role in acquired immunity (20). Although we did not observe
differences in the numbers of B. abortus CFU in wild-type and
knockout mice at 60 days postinfection, well after the onset of
adaptive immunity, our data do not rule out the possibility that
oxidative and nitrosative killing mechanisms may play a role in
resistance to reinfection or infection in vaccinated hosts.
The lack of a requirement for both NADPH oxidase and
iNOS in control of B. abortus infection contrasts with data
obtained for acute S. enterica serovar Typhimurium infection,
in which gp91phox knockout mice exhibit increased organ loads
and succumb rapidly to infection with an attenuated isolate,
while onset of mortality in iNOS knockout mice occurs approx-
imately 1 week later (27). However, our findings resemble
those obtained with a murine model of pulmonary tuberculo-
sis, in which IFN- was also required for containment of bac-
terial infection but neither NADPH oxidase nor iNOS was a
critical mediator controlling bacterial multiplication (6–8).
Similarly, Ko et al. found that whereas IRF-1 knockout mice
succumbed rapidly to B. abortus infection, both gp91phox and
Nos2 knockout mice had only slightly higher organ loads of B.
abortus than the parent mouse strains (25). Since both tuber-
culosis and brucellosis are chronic infections, the host may use
a common IFN--dependent mechanism for controlling these
infections that is independent of NADPH oxidase and iNOS.
The J774.D9 cells activated with IFN- did not produce NO
(data not shown), but they controlled replication of B. abortus
significantly better than nonactivated macrophages controlled
replication (Fig. 1). These data suggest that macrophage acti-
vation by IFN- may induce expression of killing mechanisms
that are independent of iNOS and NADPH oxidase. In the
case of Mycobacterium avium infection, it has been shown that
activation of macrophages by IFN- increases acidification and
alters maturation of the M. avium-containing vacuole (38).
Similarly, treatment of S. enterica serovar Typhimurium-in-
fected macrophages with IFN- has been shown to increase
fusion of Salmonella-containing vacuoles with lysosomes (23).
IFN- has also been shown to regulate intracellular cholesterol
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distribution, which has been shown to influence entry of B. suis
into macrophages (29, 31). Like M. avium and other intracel-
lular pathogens, B. abortus, B. suis, and Brucella melitensis have
been shown to alter endocytic trafficking to establish a com-
partment favorable for intracellular replication. The virB locus
has been shown to be required for modulation of intracellular
trafficking in HeLa cells (5, 10). We have found that in non-
activated macrophages, the numbers of B. abortus wild-type
CFU recovered are 1 to 2 logs higher than the numbers of virB
mutant CFU recovered at 48 h (Fig. 1 A). However, after
IFN- activation, the number of wild-type CFU is similar to
the number of virB mutant CFU. Given the role of the virB
genes in intracellular trafficking of Brucella spp. (5, 10), it is
tempting to speculate that as in M. avium, IFN- activation
may alter endocytic trafficking in a manner that prevents the
action of the B. abortus VirB proteins from establishing a
replicative niche in the macrophage. Further experiments will
be required to understand the mechanism by which the B.
abortus virB locus mediates intracellular replication of this
organism in macrophages.
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